Literature DB >> 2461961

Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies.

J R Stanley1, T Tanaka, S Mueller, V Klaus-Kovtun, D Roop.   

Abstract

Autoantibodies from bullous pemphigoid (BP) patients define a 230-kD protein found in the basement membrane of stratified squamous epithelia. The purpose of this study was to isolate and characterize a cDNA clone with coding sequences for BP antigen. Poly(A+) RNA derived from total RNA of cultured keratinocytes was used, with oligo-dT priming, to construct a cDNA library in the lambda gt11 expression vector, which was screened by the immunoperoxidase method with one BP serum. One darkly stained clone, called here the BP clone, was further characterized. 9 of 9 BP sera, but none of 6 normal and 11 pemphigus sera, bound the plaques of this BP clone. Furthermore, BP IgG affinity purified on plaques of this clone, but not unrelated clones, bound the epidermal basement membrane by immunofluorescence and immunoprecipitated the 230-kD BP antigen from extracts of cultured keratinocytes. Eco RI digestion of the BP clone's cDNA insert demonstrated a 680- and 1,500-bp fragment. Northern blots of total keratinocyte RNA showed that complementary riboprobes transcribed from both fragments hybridized to a 9-kb RNA. Dideoxy DNA sequencing from the 5' end of the BP cDNA demonstrated a 1,992-bp open reading frame, encoding a peptide of 76 kD. This BP cDNA clone will be valuable for understanding the protein structure, expression, and gene organization of BP antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2461961      PMCID: PMC442765          DOI: 10.1172/JCI113803

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

Review 1.  The immunopathology of pemphigus and bullous pemphigoid.

Authors:  E H Beutner; R E Jordon; T P Chorzelski
Journal:  J Invest Dermatol       Date:  1968-08       Impact factor: 8.551

2.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

3.  Efficient isolation of genes by using antibody probes.

Authors:  R A Young; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

Review 4.  Mechanism of lesion production in pemphigus and pemphigoid.

Authors:  W M Sams; W R Gammon
Journal:  J Am Acad Dermatol       Date:  1982-04       Impact factor: 11.527

5.  The epidermal cell which selectively adheres to a collagen substrate is the basal cell.

Authors:  J R Stanley; J M Foidart; J C Murray; G R Martin; S I Katz
Journal:  J Invest Dermatol       Date:  1980-01       Impact factor: 8.551

6.  Yeast DNA topoisomerase II is encoded by a single-copy, essential gene.

Authors:  T Goto; J C Wang
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

7.  Identification and partial characterization of pemphigoid antigen extracted from normal human skin.

Authors:  J R Stanley; D T Woodley; S I Katz
Journal:  J Invest Dermatol       Date:  1984-01       Impact factor: 8.551

8.  Human upper epidermal cytoplasmic antibodies are directed against keratin intermediate filament proteins.

Authors:  H Hintner; P M Steinert; T J Lawley
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

9.  A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen.

Authors:  C C Query; J D Keene
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

10.  Specific epidermal protein markers are modulated during calcium-induced terminal differentiation.

Authors:  J R Stanley; S H Yuspa
Journal:  J Cell Biol       Date:  1983-06       Impact factor: 10.539

View more
  55 in total

Review 1.  Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases.

Authors:  J Uitto; A M Christiano
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

2.  Cloning and sequencing of rat plectin indicates a 466-kD polypeptide chain with a three-domain structure based on a central alpha-helical coiled coil.

Authors:  G Wiche; B Becker; K Luber; G Weitzer; M J Castañon; R Hauptmann; C Stratowa; M Stewart
Journal:  J Cell Biol       Date:  1991-07       Impact factor: 10.539

Review 3.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 4.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  The role of topical corticosteroids in bullous pemphigoid in the elderly.

Authors:  Pascal Joly; Juliette Fontaine; Jean-Claude Roujeau
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

6.  Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180.

Authors:  G J Giudice; H L Squiquera; P M Elias; L A Diaz
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

Review 7.  Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

Authors:  Christoph M Hammers; John R Stanley
Journal:  Annu Rev Pathol       Date:  2016-02-22       Impact factor: 23.472

8.  Genetic alterations at the Bpag1 locus in dt mice and their impact on transcript expression.

Authors:  Madeline Pool; Céline Boudreau Larivière; Gilbert Bernier; Kevin G Young; Rashmi Kothary
Journal:  Mamm Genome       Date:  2005-12-08       Impact factor: 2.957

9.  In vitro cell-free synthesis of bullous pemphigoid polypeptide.

Authors:  S Miyakawa; S Tajima; T Nishikawa
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

10.  The role of complement in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; S J Swartz; J A Fairley; G O Till; J L Troy; L A Diaz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.